Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
Biomarkers.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wright Gemma Natalie, Dodds James Neil, Punnota Rifa Sanjida, Vicidomini Roberto, Edison Paul
Аннотация
BACKGROUND: There has been a recent focus within Alzheimer's Disease (AD) research on potential CSF biomarkers as diagnostic tools. PET imaging and CSF biomarkers have been used to determine the amyloid status of individuals when characterising AD. While these measures have largely correlated with each other, it is also suggested that there could be patients who can have discordant results. However, it is still unclear what proportion of AD subjects demonstrate the discordance. Additionally, whether these changes are associated with different pathological and clinical characteristics of the patients. Here, we investigated the discordance between CSF Aβ42:40 and amyloid status and evaluated whether there are any significant changes in their levels of tau aggregation.
METHOD: 313 participants' data were selected from the ADNI database. The cutoff for Aβ42:40 was then calculated using the Youden Index resulting from receiver operating characteristic (ROC) curve. The formula used was J = maxc {Se (c) + Sp (c) - 1}, resulting in a maximum cutoff of J = 0.057 for Aβ42:40. This cutoff produced a discordance rate of 10.5%, with n = 33 of 313 patients being discordant. We then performed t-tests to investigate the potential clinical differences between concordant and discordant patients.
RESULT: Independent samples t-tests indicated that levels of pTau181 and total Tau significantly differed between the concordant and discordant groups. pTau181 was significantly lower in the discordant group (t(71.2)=-3.166, p = .002), as was Tau (t(53.9)=-2.046, p = .046). Further data is found in Figure 1.
CONCLUSION: Demonstration of different levels of tau deposition in the discordant groups implies there may be other pathological processes influencing neurodegeneration in these subjects. A discordance of 10% between CSF amyloid and PET amyloid implies that we should evaluate these subjects in greater detail before enrolling them in intervention studies. References 1. Hansson, O. et al. (2019). https://doi.org/10.1186/s13195-019-0485-0 2. Pyun, JM. et al. (2024) https://doi.org/10.1038/s41398-024-02766-6.
METHOD: 313 participants' data were selected from the ADNI database. The cutoff for Aβ42:40 was then calculated using the Youden Index resulting from receiver operating characteristic (ROC) curve. The formula used was J = maxc {Se (c) + Sp (c) - 1}, resulting in a maximum cutoff of J = 0.057 for Aβ42:40. This cutoff produced a discordance rate of 10.5%, with n = 33 of 313 patients being discordant. We then performed t-tests to investigate the potential clinical differences between concordant and discordant patients.
RESULT: Independent samples t-tests indicated that levels of pTau181 and total Tau significantly differed between the concordant and discordant groups. pTau181 was significantly lower in the discordant group (t(71.2)=-3.166, p = .002), as was Tau (t(53.9)=-2.046, p = .046). Further data is found in Figure 1.
CONCLUSION: Demonstration of different levels of tau deposition in the discordant groups implies there may be other pathological processes influencing neurodegeneration in these subjects. A discordance of 10% between CSF amyloid and PET amyloid implies that we should evaluate these subjects in greater detail before enrolling them in intervention studies. References 1. Hansson, O. et al. (2019). https://doi.org/10.1186/s13195-019-0485-0 2. Pyun, JM. et al. (2024) https://doi.org/10.1038/s41398-024-02766-6.